Picture of Rocket One logo

RKTO — Rocket One Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-26.44%
3m-32.69%
6m-36.39%
1yr-64.14%
Volume Change (%)
10d/3m-84.37%
Price vs... (%)
52w High-77.65%
50d MA-20.21%
200d MA-36.56%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-160.58%
Return on Equity-148.47%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202631st Dec 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Rocket One EPS forecast chart

Profile Summary

Rocket One Inc. is an artificial intelligence (AI) semiconductor infrastructure company. The Company is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic artificial intelligence (AI) chip technology designed for radiation-tolerant, energy-constrained environments such as low-earth orbit, deep-space platforms, and defense systems. It operates through two segments, which include Biopharmaceutical and AI semiconductor infrastructure. It is also focused on a nanomagnetic matrix multiplier, Skyrmion Spintronic memory, and Swarm Stage AI. The Company's biotechnology pipeline includes HT-001, HT-KIT, HT-ALZ, and its glial cell line derived neurotrophic factor (GDNF)-based metabolic program. The HT-001 is used to treat epidermal growth factor receptor (EGFR)-induced skin disorders. The HT-KIT drug is used to treat the receptor tyrosine kinase KIT in mast cells.

Directors

Last Annual
December 31st, 2025
Last Interim
June 30th, 2026
Incorporated
May 16th, 2017
Public Since
February 15th, 2019
No. of Shareholders
88
No. of Employees
2
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
24,897,581

RKTO Share Price Performance

Upcoming Events for RKTO

Q3 2026 Rocket One Inc Earnings Release

Rocket One Inc Annual Shareholders Meeting

Q4 2026 Rocket One Inc Earnings Release

Similar to RKTO

Picture of 60 Degrees Pharmaceuticals logo

60 Degrees Pharmaceuticals

us flag iconNASDAQ Capital Market

Picture of Abeona Therapeutics logo

Abeona Therapeutics

us flag iconNASDAQ Capital Market

Picture of Akari Therapeutics logo

Akari Therapeutics

us flag iconNASDAQ Capital Market

Picture of Akebia Therapeutics logo

Akebia Therapeutics

us flag iconNASDAQ Capital Market

Picture of Alpha Cognition logo

Alpha Cognition

us flag iconNASDAQ Capital Market

FAQ